GIANFILIPPI, Gianluca

GIANFILIPPI, Gianluca  

Mostra records
Risultati 1 - 13 di 13 (tempo di esecuzione: 0.013 secondi).
Titolo Data di pubblicazione Autore(i) File
Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination 1-gen-2021 Salvagno, Gian Luca; Henry, Brandon M.; di Piazza, Giovanni; Pighi, Laura; De Nitto, Simone; Bragantini, Damiano; Gianfilippi, Gian Luca; Lippi, Giuseppe
Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers 1-gen-2021 Salvagno, Gian Luca; Henry, Brandon; Di Piazza, Giovanni; Pighi, Laura; De Nitto, Simone; Bragantini, Damiano; Gianfilippi, Gianluca; Lippi, Giuseppe
Clinical assessment of the Roche SARS-CoV-2 rapid antigen test 1-gen-2021 Salvagno, Gian Luca; Gianfilippi, Gianluca; Bragantini, Damiano; Henry, Brandon M; Lippi, Giuseppe
Comparative longitudinal variation of total IgG and IgA anti-SARS-CoV-2 antibodies in recipients of BNT162b2 vaccination 1-gen-2022 Lippi, Giuseppe; Salvagno, Gian Luca; Henry, Brandon M.; Pighi, Laura; De Nitto, Simone; Gianfilippi, Gianluca
Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals 1-gen-2022 Salvagno, Gian Luca; Henry, Brandon M; Pighi, Laura; De Nitto, Simone; Gianfilippi, Gianluca; Lippi, Giuseppe
Humoral response post-BNT162b2 single booster in pre-vaccination baseline SARS-CoV-2 seronegative and seropositive subjects 1-gen-2022 Salvagno, GIAN LUCA; Henry, Brandon M.; Pighi, Laura; DE NITTO, Simone; Gianfilippi, Gianluca; Lippi, Giuseppe
Longitudinal monitoring of anti-SARS-CoV-2 RBD IgG antibodies after BNT162b2 vaccination in healthcare workers 1-gen-2022 Salvagno, Gian Luca; Henry, Brandon Michael; Pighi, Laura; De Nitto, Simone; Gianfilippi, Gianluca; Lippi, Giuseppe
Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay 1-gen-2021 Salvagno, Gian Luca; Henry, Brandon M; Pighi, Laura; De Nitto, Simone; Gianfilippi, Gian Luca; Lippi, Giuseppe
Performance of Fujirebio Espline SARS-CoV-2 rapid antigen test for identifying potentially infectious individuals 1-gen-2022 Salvagno, Gian Luca; Nocini, Riccardo; Gianfilippi, Gianluca; Fiorio, Giacomo; Pighi, Laura; De Nitto, Simone; Cominziolli, Annalisa; Henry, Brandon M; Lippi, Giuseppe
The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals six months after BNT162b2 vaccination is consistent with the need for vaccine boosters 1-gen-2022 Salvagno, Gl; Henry, Bm; Pighi, L; De Nitto, S; Gianfilippi, G; Lippi, G.
Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit 1-gen-2021 Salvagno, Gian Luca; Gianfilippi, Gianluca; Pighi, Laura; De Nitto, Simone; Henry, Brandon M.; Lippi, Giuseppe
Three-month ad interim analysis of total anti-SARS-CoV-2 antibodies in healthy recipient of a single BNT162b2 vaccine booster 1-gen-2022 Salvagno, Gian Luca; Henry, Brandon M; Pighi, Laura; De Nitto, Simone; Gianfilippi, Gianluca; Lippi, Giuseppe
Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers 1-gen-2021 Salvagno, Gian Luca; Henry, Brandon M; Pighi, Laura; De Nitto, Simone; Gianfilippi, Gian Luca; Lippi, Giuseppe